How Actress Lili Reinhart Is Scaling A Skincare Brand And Fixing The Broken Indie Film Model https://t.co/QTAC8jjaQl ...

Actress Lili Reinhart couldn’t find a solution to her acne, so she launched her own skincare line, Personal Day. Thanks to her viral TikTok following, the #ForbesUnder30 alum is now cleaning up with $10 million in sales. Read more: https://t.co/f0BTkfm410 📸: Sebastian Nevols for Forbes ...

Waldencast plc (NASDAQ:WALD) is a leading skincare company specializing in advanced treatments for skin aging, damage, and other concerns. With its foundation in 1988 and headquarters in White Plains, New York, Waldencast has established a strong market presence through its professional distribution channels. The company's product lineup, including Obagi Medical and Obagi Clinical, is renowned for improving skin tone and texture.The financial and market analysis of Waldencast reveals several key insights:Th ...

Actress Lili Reinhart couldn’t find a solution to her acne, so she launched her own skincare line, Personal Day. Thanks to her viral TikTok following, the #ForbesUnder30 alum is now cleaning up with $10 million in sales. Read more: https://t.co/f0BTkfm410 📸: Sebastian Nevols for Forbes ...

L’Oréal is doubling its stake in Galderma to 20%, buying shares from EQT-led investors as it deepens its push into skincare drugs https://t.co/d6WcvIZ6IV ...

‘Riverdale’ star @lilireinhart couldn’t find a solution to her acne, so she launched her own skincare line, Personal Day. Thanks to her viral TikTok following, the #ForbesUnder30 alum is now cleaning up with $10 million in sales. https://t.co/f0BTkfm410 📸: Sebastian Nevols for Forbes ...

SAN DIEGO, CA / ACCESS Newswire / December 4, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a science-driven leader in dermatologic solutions, today announced that it will soon reveal its new brand name for its over-the-counter ("OTC") skincare business representing its evolution toward a more direct, science-first era of dermatologic innovation. While the name remains confidential until the formal unveiling, the Company is offering a first look at the mission a ...

Xiamen, China, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Meiwu Technology Co., Ltd. (hereinafter referred to as " Meiwu" or the "Company") (NASDAQ: WNW), a leading integrated platform in the beauty industry, announced that the Company signed a non-binding Strategic Cooperation Memorandum of Understanding ("MOU") on November 25, 2025, with Real BioTech (Qingdao) Ltd. ("Real Biotech"), a marine biotechnology enterprise based in Qingdao, China. The MOU aims to establish a strategic partnership between the two parties, ...

Core Insights - Waldencast plc is a skincare company focused on advanced treatments for skin aging and damage, with a portfolio that includes Obagi Medical and Obagi Clinical [1] - The consensus price target for Waldencast has decreased from $4.80 to $3.25, indicating increased caution among analysts, although D.A. Davidson has set a higher target of $15.50 [2] - The company faces challenges such as margin pressure, negative earnings, and significant debt, but it continues to show solid revenue growth [2] Financial Performance - In Q1 2025, Waldencast reported net revenue of $65.4 million, a 4.1% decline from the previous year, with an adjusted gross margin of 76.4% [2] - The company's Q4 2024 results showed net revenue of $72.1 million, representing a 29.4% growth, and an adjusted EBITDA of $11.2 million, which doubled from Q4 2023 [3] - Waldencast's financial profile is characterized by negative cash flow and high leverage, but it maintains manageable liquidity and a long debt runway until 2030 [3] Analyst Insights - Analysts from firms like Alliance Global Partners and TD Cowen have participated in recent earnings calls, discussing the company's strategies to navigate market challenges and capitalize on growth opportunities [3]

Core Insights - Oddity Tech Ltd. is set to release its quarterly earnings on November 19, 2025, with an expected EPS of $0.35 and revenue of approximately $145.47 million [1][6] Company Developments - The launch of Methodiq, a telehealth platform for medical skincare, signifies Oddity's strategic entry into the medical-grade skincare market, competing with companies like Hims [2][6] - Methodiq offers 28 new products targeting skin conditions such as acne and eczema, with prices ranging from $29 to $59, making them accessible to a broad audience [2] - The development of Methodiq took four years and integrates investments in biotechnology and AI-based computational imaging, allowing for online diagnosis and personalized treatments [3] Financial Performance - Oddity has a price-to-earnings (P/E) ratio of 18.89, indicating the market's valuation of its earnings [4][6] - The price-to-sales ratio stands at 2.76, reflecting investor willingness to pay per dollar of sales [4] - The enterprise value to sales ratio is 1.92, showing the company's total valuation relative to its sales [4] - The company maintains a low debt-to-equity ratio of 0.065, indicating conservative debt use [5] - A current ratio of 6.32 suggests strong liquidity, ensuring the company can cover short-term liabilities [5] - An earnings yield of 5.29% demonstrates Oddity's ability to generate earnings from each dollar invested [5]